TY - CHAP M1 - Book, Section TI - Epidemiology of Gynecologic Cancers, Clinical Trials, and Statistical Considerations A1 - Brewster, Wendy R. A1 - Tewari, Krishnansu S. A2 - Karlan, Beth Y. A2 - Bristow, Robert E. A2 - Li, Andrew J. Y1 - 2015 N1 - T2 - Gynecologic Oncology: Clinical Practice and Surgical Atlas AB - The burden of cancer on our population is expected to rise sharply over the next 20 years. This is the result of the aging and growth of the world's population, alongside an increasing adoption of cancer-causing behaviors, particularly smoking and increasing obesity. Overall, cancer incidence is expected to increase by 45% between 2010 and 2030, with the greatest increase borne by older adults and minorities. By 2030, approximately 70% of all cancers will be diagnosed in older adults, and 28% of all cancers will be diagnosed in minorities.1 Resources will be required to effect and optimize cancer prevention, screening, and early detection. Meaningful improvements in cancer therapy and/or prevention strategies will be required to prevent a dramatic increase in the number of cancer deaths over the next 20 years. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - obgyn.mhmedical.com/content.aspx?aid=1106569530 ER -